Biodegradable Ph-Responsive Amorphous Calcium Carbonate Nanoparticles As Immunoadjuvants for Multimodal Imaging and Enhanced Photoimmunotherapy.

Meng Wang,Benqing Zhou,Lu Wang,Feifan Zhou,Nataliya Smith,Debra Saunders,Rheal A. Towner,Jun Song,Junle Qu,Wei R. Chen
DOI: https://doi.org/10.1039/d0tb01453b
IF: 7.571
2020-01-01
Journal of Materials Chemistry B
Abstract:Development of bioresponsive theranostic nanoparticles to enhance cancer diagnostics and control cancer metastasis is highly desirable. In this study, we developed such a bioresponsive theranostic nanoparticle for synergistic photoimmunotherapy. In particular, these nanoparticles were constructed by embedding indocyanine green (ICG) into Mn2+-doped amorphous calcium carbonate (ACC(Mn)) nanoparticles, followed by loading of the Toll-like-receptor-7 agonist imiquimod (IMQ). The IMQ@ACC(Mn)-ICG/PEG nanoparticles respond to the acidic pH of the tumor microenvironment (TME) and co-deliver ICG and IMQ into the tumor. Selective phototherapy was achieved upon activation using a near-infrared laser. In the presence of IMQ and arising from phototherapeutically treated tumor cells, tumor-associated antigens give rise to a strong antitumor immune response. Reversal of the immunosuppressive TME via H+ scavenging of the tumor through ACC nanoparticles effectively inhibits tumor metastases. Moreover, the combination of ICG and Mn2+ also serves as an advanced contrast agent for cancer multimode imaging. Overall, these bioresponsive nanoparticles provide a promising approach for cancer theranostics with promising potential for future clinical translation.
What problem does this paper attempt to address?